Drug Susceptibility tests in Dubai & UAE

Compare available Drug Susceptibility tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

650.00–2,200.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Drug Susceptibility test prices

Showing 1–10 of 10 matching tests.

Drug Susceptibility diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-882 Cultured AFB Anti-Tubercular Drug Susceptibility Testing (DST) for Isoniazid (INH) Test This test determines the susceptibility or resistance of Mycobacterium tuberculosis complex to the anti-TB drug isoniazid.	Pure cultured isolate of Mycobacterium tuberculosis complex	21 days from receipt of pure culture	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility of Mycobacterium tuberculosis to Isoniazid", "Phenotypic resistance profile"] Parameters [] Preparation ["No direct preparation needed from the patient", "Initial specimen (sputum/respiratory sample) must be collected under medical supervision"] Indications ["Diagnosis of tuberculosis", "Monitoring treatment response", "Identification of drug resistance patterns"] Measurement technique Confirm with laboratory Codes LOINC: 28959-4 ICD-10: A15.0, A15.7, Z86.13 Clinical summary This test determines the susceptibility or resistance of Mycobacterium tuberculosis complex to the anti-TB drug isoniazid.
TEST-873 Cultured AFB Anti-Tubercular DST for Clofazimine Test This test evaluates the susceptibility of Mycobacterium tuberculosis to the anti-TB drug clofazimine using a phenotypic culture method.	Pure bacterial isolate (from prior sputum or tissue culture)	21 days from pure isolate	700.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Clofazimine susceptibility", "Mycobacterium tuberculosis growth"] Parameters [] Preparation ["No direct patient preparation required", "Sample is a pure bacterial isolate from prior culture"] Indications ["Diagnosis of MDR-TB", "Guidance for MDR-TB treatment selection", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 29580-3 ICD-10: A15.0, Z16.39, U82.2 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis to the anti-TB drug clofazimine using a phenotypic culture method.
TEST-889 Cultured AFB Antitubercular Drug Susceptibility Test This diagnostic test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the anti-tubercular drug pyrazinamide.	Archival Tissue Specimen – Pure growth isolate of Mycobacterium tuberculosis complex on solid or liquid medium	21 working days from pure growth receipt	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mycobacterium tuberculosis resistance to pyrazinamide", "Phenotypic growth inhibition"] Parameters [{"name": "Pyrazinamide Susceptibility", "reference_range": "Sensitive / Resistant"}] Preparation ["No specific patient preparation required; sample is a pure culture isolate."] Indications ["Diagnosis of drug-resistant tuberculosis", "Monitoring treatment response", "Guiding selection of anti-tubercular therapy"] Measurement technique Confirm with laboratory Codes LOINC: 22334-7 ICD-10: Z16.24, A15.0, Z20.1 Clinical summary This diagnostic test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the anti-tubercular drug pyrazinamide.
TEST-877 Cultured AFB Antitubercular Drug Susceptibility Testing — Ethionamide (DST) Test This test determines the susceptibility of Mycobacterium tuberculosis complex isolates to the anti-TB drug ethionamide.	Pure Bacterial Isolates (M. tuberculosis complex culture)	21 Calendar Days	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mycobacterium tuberculosis complex susceptibility to ethionamide", "Minimum Inhibitory Concentration (MIC)"] Parameters [{"name": "Minimum Inhibitory Concentration (MIC)", "reference_range": null}] Preparation [] Indications ["Diagnosis of MDR-TB", "Guidance for second-line anti-TB therapy", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 50416-1 ICD-10: Z16.342, A15.0, Z11.1 Clinical summary This test determines the susceptibility of Mycobacterium tuberculosis complex isolates to the anti-TB drug ethionamide.
TEST-899 Cultured AFB Antitubercular DST (Rapid 11-Drugs Panel) Test This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to 11 key anti-tubercular drugs using automated fluorometric growth-based detection.	Pure culture isolate of Mycobacterium tuberculosis complex	21 Days (report post-incubation of submitted pure culture)	2,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to Isoniazid", "Susceptibility to Rifampicin", "Susceptibility to Pyrazinamide", "Susceptibility to Ethambutol", "Susceptibility to Fluoroquinolones", "Susceptibility to Aminoglycosides", "Susceptibility to Injectables"] Parameters [{"name": "Isoniazid", "reference_range": "Susceptible/Resistant"}, {"name": "Rifampicin", "reference_range": "Susceptible/Resistant"}, {"name": "Pyrazinamide", "reference_range": "Susceptible/Resistant"}, {"name": "Ethambutol", "reference_range": "Susceptible/Resistant"}, {"name": "Fluoroquinolones", "reference_range": "Susceptible/Resistant"}, {"name": "Aminoglycosides", "reference_range": "Susceptible/Resistant"}, {"name": "Injectables", "reference_range": "Susceptible/Resistant"}] Preparation ["No specific patient preparation required; sample collection is hospital-based."] Indications ["Diagnosis of drug-resistant tuberculosis", "Guidance for treatment selection in MDR-TB cases", "Monitoring treatment response"] Measurement technique Confirm with laboratory Codes LOINC: 53501-2 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to 11 key anti-tubercular drugs using automated fluorometric growth-based detection.
TEST-878 Cultured AFB Antitubercular DST Ethambutol Test This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the antitubercular drug ethambutol.	Mycobacterial Culture Isolate (from respiratory or extrapulmonary specimen)	21 Days from Receipt of Pure Isolate	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Phenotypic resistance or sensitivity of Mycobacterium tuberculosis to ethambutol"] Parameters [] Preparation [] Indications ["Diagnosis of active tuberculosis", "Monitoring treatment response", "Guiding therapy in drug-resistant TB cases", "Baseline susceptibility testing per UAE National TB Program guidelines"] Measurement technique Confirm with laboratory Codes LOINC: 29579-0 ICD-10: Z16.24, A15.0, Z15.89 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to the antitubercular drug ethambutol.
TEST-893 Cultured AFB Antitubercular DST Rapid 10-Drug Panel Test This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex isolates to ten antitubercular drugs.	Mycobacterium tuberculosis complex pure culture isolate	21 working days from receipt of pure culture	2,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to Isoniazid (INH)", "Susceptibility to Rifampicin (RIF)", "Susceptibility to Ethambutol (EMB)", "Susceptibility to Pyrazinamide (PZA)", "Susceptibility to Moxifloxacin", "Susceptibility to Linezolid", "Susceptibility to other relevant drugs"] Parameters [{"name": "Isoniazid (INH)", "reference_range": "Susceptible/Resistant"}, {"name": "Rifampicin (RIF)", "reference_range": "Susceptible/Resistant"}, {"name": "Ethambutol (EMB)", "reference_range": "Susceptible/Resistant"}, {"name": "Pyrazinamide (PZA)", "reference_range": "Susceptible/Resistant"}, {"name": "Moxifloxacin", "reference_range": "Susceptible/Resistant"}, {"name": "Linezolid", "reference_range": "Susceptible/Resistant"}] Preparation ["No special patient preparation is necessary as the test is performed on a laboratory-grown pure isolate."] Indications ["Diagnosis of drug-resistant tuberculosis", "Guidance for initial tuberculosis therapy", "Monitoring for acquired drug resistance"] Measurement technique Confirm with laboratory Codes LOINC: 49850-1 ICD-10: Z16.24, A15.0 Clinical summary This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex isolates to ten antitubercular drugs.
TEST-916 Cultured AFB Antitubercular DST Rapid Second‑Line Panel Test This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to five critical second-line antitubercular drugs using an automated phenotypic method.	Pure, viable Mycobacterium tuberculosis complex isolate (archival specimen)	21 days from receipt of pure culture	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to Isoniazid", "Susceptibility to Rifampicin", "Susceptibility to Fluoroquinolones", "Susceptibility to Injectable Agents", "Susceptibility to Ethambutol"] Parameters [] Preparation ["No patient preparation is needed."] Indications ["Suspected or confirmed MDR-TB", "Prior exposure to second-line TB drugs", "Failure of first-line TB treatment", "Need for personalized MDR-TB therapy"] Measurement technique Confirm with laboratory Codes LOINC: 100936-3 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis isolates to five critical second-line antitubercular drugs using an automated phenotypic method.
TEST-896 Cultured AFB Antitubercular PAS Drug Susceptibility Test This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex to the antitubercular drug p-aminosalicylic acid (PAS).	Pure culture isolate of Mycobacterium tuberculosis complex	21 days from receipt of pure culture isolate	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["In-vitro susceptibility of Mycobacterium tuberculosis complex to p-aminosalicylic acid (PAS)", "Minimum Inhibitory Concentration (MIC) for PAS"] Parameters [] Preparation [] Indications ["Suspected or confirmed MDR-TB", "Need to guide second-line antitubercular therapy", "Monitoring treatment response in MDR-TB cases"] Measurement technique Confirm with laboratory Codes LOINC: 50525-3 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of cultured Mycobacterium tuberculosis complex to the antitubercular drug p-aminosalicylic acid (PAS).
TEST-905 Rapid AFB Culture‑Based Drug Susceptibility Testing (5‑Drug Panel) Test This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to five first-line antitubercular drugs.	Pure isolate of Mycobacterium tuberculosis complex	21 days from receipt of pure growth	1,300.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Susceptibility to Isoniazid", "Susceptibility to Rifampicin", "Susceptibility to Ethambutol", "Susceptibility to Pyrazinamide", "Susceptibility to Streptomycin"] Parameters [] Preparation ["No patient preparation is needed as the test uses a pure laboratory isolate."] Indications ["Suspected tuberculosis", "Need for drug susceptibility testing", "Detection of multidrug-resistant tuberculosis (MDR-TB)", "Guiding antitubercular therapy"] Measurement technique Confirm with laboratory Codes LOINC: 100321-1 ICD-10: A15.0 Clinical summary This test evaluates the susceptibility of Mycobacterium tuberculosis complex isolates to five first-line antitubercular drugs.

Category overview

Drug Susceptibility: overview

When an infectious pathogen has been isolated, determining the exact concentration of medication required to kill it is the most critical step in preventing long-term systemic damage. As a highly specialized diagnostic tool in our Microbiology department, Drug Susceptibility testing evaluates the physical response of your specific bacterial or mycobacterial strain against a broad panel of antimicrobial agents. Utilizing advanced automated minimum inhibitory concentration (MIC) and disk diffusion technology, this crucial screening eliminates the diagnostic guesswork of empiric treatments, safely guiding your healthcare provider in selecting the most potent, highly effective medication while minimizing harmful side effects and preventing the development of further resistance. Consistently trusted for specialized diagnostic excellence among top diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising analytical precision, and remarkably fast turnaround times. Empower your path to a complete cure—schedule your drug susceptibility testing in UAE, coordinate a secure clinical sample collection, or consult our expert infectious disease specialists today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.